Earnings Ahead

ITCI - Intra-Cellular Therapies Inc.

62.7 0.09 0.14

Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc.

About

Profile


Headquarters

United States of America


Intraday

High
-
Low
-

52-week

High
-
Low
-

ITCI

The stock soared nearly 34% after Johnson & Johnson announced it will take over the neurological treatment company for $132 per share. That values Intra-Cellular Therapies at $14.6 billion. Shares of Johnson & Johnson were flat.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Intra-Cellular Therapies GAAP EPS of -$0.30 beats by $0.15, revenue of $132M misses by $3.67M
  • Intra-Cellular Therapies Q4 2023 Earnings Preview
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Bristol-Karuna deal: What other biotechs might be in M&A crosshairs?
  • Intra-Cellular Therapies gains amid repeated takeover speculation
  • Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34, revenue of $126.17M beats by $6.94M
  • Intra-Cellular Therapies Q3 2023 Earnings Preview
  • Intra-Cellular Therapies beats top and bottom line estimates, gives FY guidance
  • Intra-Cellular Therapies Q2 2023 Earnings Preview
  • Intra-Cellular Therapies GAAP EPS of -$0.46 beats by $0.16, revenue of $95.31M beats by $2.9M
  • Intra-Cellular Therapies Q1 2023 Earnings Preview
  • Morgan Stanley's Wilson screens for stocks as earnings stabilize but data disappoints
  • What is behind biotech M&A resurgence?
  • Morgan Stanley starts Intra-Cellular at Overweight on schizophrenia therapy
  • Alnylam, Intra-Cellular among potential biotech take-out targets - RBC
  • Intra-Cellular jumps 14% after early data for depression candidate
  • Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M
  • Intra-Cellular Therapies Q4 2022 Earnings Preview
  • Intra-Cellular stock surges 11% as bipolar depression drug sales skyrockets in Q3
  • Intra-Cellular Therapies GAAP EPS of -$0.57 beats by $0.25, revenue of $71.9M beats by $5.9M
Date Price Open High Low Vol Change ER
Oct 9, 2023 52.02 50.7
52.03
49.54
869K 2.06%
Oct 6, 2023 50.97 51.06
51.97
50.76
541K -0.7%
Oct 5, 2023 51.33 50.8
51.7
50.74
637K 0.82%
Oct 4, 2023 50.91 51.42
51.44
50.36
394K -1.13%
Oct 3, 2023 51.49 52.47
52.94
51.18
774K -1.91%
 
Oct 2, 2023 52.49 51.83
52.74
51.66
766K 0.77%
Sep 29, 2023 52.09 54.08
54.35
51.93
615K -3.18%
Sep 28, 2023 53.8 54.16
54.94
53.67
431K -0.59%
Sep 27, 2023 54.12 54.03
54.47
53.01
588K 0.69%
Sep 26, 2023 53.75 53.95
54.9
53.21
770K -0.96%
Sep 25, 2023 54.27 53.45
54.75
52.93
498K 0.93%
Sep 22, 2023 53.77 52.8
54.73
52.75
612K 2.17%
Sep 21, 2023 52.63 54.03
54.07
52.62
626K -3.32%
Sep 20, 2023 54.44 54.36
54.92
54
771K 0.15%
Sep 19, 2023 54.36 53.9
54.41
53.69
558K 0.83%
Sep 18, 2023 53.91 54.82
54.82
52.75
714K -2.04%
Sep 15, 2023 55.03 56.5
56.54
54.52
1.0M -2.41%
Sep 14, 2023 56.39 57.33
57.88
56.28
461K -1.54%
Sep 13, 2023 57.27 58.96
59.9
56.85
717K -3.44%
Sep 12, 2023 59.31 58.96
59.73
58.2
499K 1.07%
Sep 11, 2023 58.68 58.88
59.1
58.2
384K -0.03%
Sep 8, 2023 58.7 57.72
59.26
55.98
526K 1.98%
Sep 7, 2023 57.56 57.86
58.18
56.92
409K 0.17%
Sep 6, 2023 57.46 57.1
57.49
56.19
577K 0.81%
Sep 5, 2023 57 55.61
57.6
55.42
902K 2.04%
Sep 1, 2023 55.86 55.59
56.47
55.54
586K 0.61%
Aug 31, 2023 55.52 55.91
56.44
55.46
586K 0.27%
Aug 30, 2023 55.37 54.97
55.37
54.85
707K 0.95%
Aug 29, 2023 54.85 55.34
55.78
54.76
656K -0.8%
Aug 28, 2023 55.29 55.16
55.47
54.96
370K 0.42%
Aug 25, 2023 55.06 55
55.6
54.45
558K -0.09%
Aug 24, 2023 55.11 55.55
55.85
55.02
508K -0.86%
Aug 23, 2023 55.59 56.55
56.94
55.44
446K -0.94%
Aug 22, 2023 56.12 56.03
56.74
55.72
536K 0%
Aug 21, 2023 56.12 56.31
57.63
55.15
648K -0.21%
Aug 18, 2023 56.24 54.96
56.99
54.94
812K 1.68%
Aug 17, 2023 55.31 56.48
56.79
55.14
731K -2.11%
Aug 16, 2023 56.5 57.58
58.07
56.4
619K -2.28%
Aug 15, 2023 57.82 57.76
59.48
57.42
476K 0.10%
Aug 14, 2023 57.76 58.29
58.4
57.3
817K -1.45%
Aug 11, 2023 58.61 58
59.16
57.88
332K 0.70%
Aug 10, 2023 58.2 58.02
59.07
57.85
341K 0.22%
Aug 9, 2023 58.07 57.93
58.48
57.04
417K 0.09%
Aug 8, 2023 58.02 58.8
59.5
57.66
634K -1.51%
Aug 7, 2023 58.91 58.93
59.35
58.27
613K 0.67%
Aug 4, 2023 58.52 58.9
60.26
58.52
661K -0.63%
Aug 3, 2023 58.89 59.08
61.95
57.28
1.5M -3.25%
Aug 2, 2023 60.87 60.6
61.7
60.04
617K -0.03%
Aug 1, 2023 60.89 61.97
62.07
60.6
419K -1.54%
Jul 31, 2023 61.84 61
62.66
60.33
568K 1.69%
Jul 28, 2023 60.81 62.44
62.44
58.61
975K -1.86%
Jul 27, 2023 61.96 61.71
62.73
61.26
446K 0.99%
Jul 26, 2023 61.35 60.4
61.49
60.27
502K 1.02%
Jul 25, 2023 60.73 61.27
61.89
60.71
398K -1.3%
Jul 24, 2023 61.53 61.98
62.36
61.13
405K -0.89%
Jul 21, 2023 62.08 62.69
63.03
61.8
598K 0.08%
Jul 20, 2023 62.03 63.1
64.25
62.02
559K -1.6%
Jul 19, 2023 63.04 62.9
63.59
61.22
627K 0.30%
Jul 18, 2023 62.85 63.63
64.35
62.67
745K -1.05%
Jul 17, 2023 63.52 63.71
65
63.26
584K 0%